ERBA Diagnostics, Inc. Reports 2014 Financial Results; Announces Delay in Filing Quarterly Report on Form 10-Q
May 18, 2015 07:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., May 18, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reported its financial results for the year ended December...
ERBA Diagnostics, Inc. Appoints Ernesina Scala as Chief Financial Officer and Chandra Krishnan as Senior Vice President Global Sales, Marketing and Business Development
May 06, 2015 07:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., May 6, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, has appointed Ernesina Scala as Chief Financial Officer...
ERBA Diagnostics, Inc. Provides an Update on the Anticipated Timing of the Filing of Its Annual Report on Form 10-K
April 30, 2015 07:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., April 30, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, provided today an update on the anticipated timing of the...
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
April 21, 2015 17:10 ET
|
ERBA Diagnostics, Inc.
MIAMI, April 21, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) (the "Company"), a fully integrated in vitro diagnostics company, announced today that, on April 17, 2015, the Company...
ERBA Diagnostics, Inc. Announces Delay in Filing Annual Report on Form 10-K
April 16, 2015 07:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., April 16, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, announced today that it is delaying the filing of its...
ERBA Diagnostics Announces Delay in Filing Annual Report on Form 10-K
April 01, 2015 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., April 1, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, announced that it is delaying the filing of its Annual...
ERBA Diagnostics Enters Agreement to Sell Former Facilities for $23 Million
March 26, 2015 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., March 26, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) announced that its wholly-owned subsidiary – Diamedix Corporation – has entered into a purchase...
Erba Diagnostics Expands U.S. Distribution Network
January 26, 2015 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Erba Diagnostics, Inc. (NYSE MKT:ERB), strengthened its U.S. distribution network by having entered into a new agreement with Government Scientific...
ERBA Diagnostics Attains CE Mark for HB Vario A1c Detection System and Reagents for Management of Diabetes
January 21, 2015 08:00 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Jan. 21, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB), has attained CE Mark clearance for the HB Vario A1c detection system and associated reagents. Monitoring A1c...
ERBA Diagnostics Webcast Alert: Moves Presentation at OneMedForum to January 13, 2015
January 12, 2015 14:01 ET
|
ERBA Diagnostics, Inc.
MIAMI LAKES, Fla., Jan. 12, 2015 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (NYSE MKT:ERB) is moving originally scheduled presentation at the OneMedForum to Tues, January 13th, 2015 at 4:40 pm PST...